The neuroprotective effect of olanzapine
dc.contributor.author | Ozan, Erol | |
dc.contributor.buuauthor | Yuluğ, Burak | |
dc.contributor.buuauthor | Bakar, Mustafa | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-9704-6173 | tr_TR |
dc.contributor.researcherid | O-8322-2016 | tr_TR |
dc.contributor.researcherid | AAD-3930-2022 | tr_TR |
dc.contributor.scopusid | 6507583384 | tr_TR |
dc.contributor.scopusid | 26643051200 | tr_TR |
dc.date.accessioned | 2024-03-28T12:55:52Z | |
dc.date.available | 2024-03-28T12:55:52Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | Yuluğ, B. vd. (2008). "The neuroprotective effect of olanzapine". Journal of Neuropsychiatry and Clinical Neurosciences, 20(1), 107-108. | en_US |
dc.identifier.endpage | 108 | tr_TR |
dc.identifier.issn | 0895-0172 | |
dc.identifier.issue | 1 | tr_TR |
dc.identifier.pubmed | 18305294 | tr_TR |
dc.identifier.scopus | 2-s2.0-39749139311 | tr_TR |
dc.identifier.startpage | 107 | tr_TR |
dc.identifier.uri | https://doi.org/10.1176/appi.neuropsych.20.1.107-a | en_US |
dc.identifier.uri | https://neuro.psychiatryonline.org/doi/full/10.1176/jnp.2008.20.1.107a | en_US |
dc.identifier.uri | https://hdl.handle.net/11452/40659 | en_US |
dc.identifier.volume | 20 | tr_TR |
dc.identifier.wos | 000253311000016 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Psychiatric Publishing | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.journal | Journal of Neuropsychiatry and Clinical Neurosciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Schizophrenia | en_US |
dc.subject | Neuroleptics | en_US |
dc.subject | Brain | en_US |
dc.subject | Neurosciences & NeurologyPsychiatry Web of Science CategoriesClinical Neurolo | en_US |
dc.subject | Psychiatry | en_US |
dc.subject.emtree | Drug vehicle | en_US |
dc.subject.emtree | Neuroleptic agent | en_US |
dc.subject.emtree | Olanzapine | en_US |
dc.subject.emtree | Animal cell | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Animal model | en_US |
dc.subject.emtree | Animal tissue | en_US |
dc.subject.emtree | Brain infarction | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Dose response | en_US |
dc.subject.emtree | Drug efficacy | en_US |
dc.subject.emtree | Letter | en_US |
dc.subject.emtree | Long term care | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Middle cerebral artery occlusion | en_US |
dc.subject.emtree | Mouse | en_US |
dc.subject.emtree | Neuroimaging | en_US |
dc.subject.emtree | Neuroprotection | en_US |
dc.subject.emtree | Neurotoxicity | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Nuclear magnetic resonance imaging | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Schizophrenia | en_US |
dc.subject.scopus | Common Carotid Artery; Fluoro Jade; Gerbillinae | en_US |
dc.subject.wos | Clinical neurology | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.subject.wos | Psychiatry | en_US |
dc.title | The neuroprotective effect of olanzapine | en_US |
dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: